MDX

Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution

Retrieved on: 
Wednesday, June 29, 2022
Efficiency, RNA polymerase II, Pandemic, COVID-19, Health care, MDX, COVID-19 vaccine, Respiratory syncytial virus, Virus, Middle East respiratory syndrome, Gene amplification, Solution, PCR, Time, RSV, Immunity, Vaccine, EU

This is expected to help small hospitals, local clinics, and public health centers effectively identify COVID-19, influenza A and B and respiratory syncytial virus (RSV).

Key Points: 
  • This is expected to help small hospitals, local clinics, and public health centers effectively identify COVID-19, influenza A and B and respiratory syncytial virus (RSV).
  • The targets include three distinct COVID-19 genes (S, RdRp, N) to reliably identify positive cases even as new variants emerge.
  • As AIOS is a fully automated (sample in result out) system, it can be operated by those without PCR experience.
  • *Syndromic testing refers to the process of simultaneously targeting multiple pathogens that have similar symptoms using a single test.

Seegene develops PCR test to detect monkeypox virus

Retrieved on: 
Tuesday, June 28, 2022
Diagnosis, CEO, World Health Organization, Contact tracing, Monkeypox virus, Pandemic, Infection, MDX, World, PCR, Multimedia, Vaccine

SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus.

Key Points: 
  • SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus.
  • The Novaplex MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.
  • The World Health Organization saysthe monkeypox virus is an "evolving health threat that requires collective attention and coordinated action," calling on member states to step up surveillance, contact tracing and testing.
  • The monkeypox virus has been detected in over 50 nations, with South Korea confirming its first case last week.

Seegene develops PCR test to detect monkeypox virus

Retrieved on: 
Tuesday, June 28, 2022
Contact tracing, Diagnosis, Monkeypox virus, Infection, Pandemic, PCR, World, CEO, MDX, World Health Organization, Vaccine

SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus.

Key Points: 
  • SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus.
  • The Novaplex MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.
  • The World Health Organization saysthe monkeypox virus is an "evolving health threat that requires collective attention and coordinated action," calling on member states to step up surveillance, contact tracing and testing.
  • The monkeypox virus has been detected in over 50 nations, with South Korea confirming its first case last week.

Honda Ties for Leading Automaker in Cars.com 2022 American-Made Index with Four Models in Top 10

Retrieved on: 
Wednesday, June 22, 2022
TLX, Marysville Auto Plant, Honda HA-420 HondaJet, Geier v. American Honda Motor Co., GE Honda Aero Engines, View, RDX, MDX, Car, Plant, GE Honda HF120, Ridge, GE, Cars.com, Multimedia, Motor vehicle, Acura, Odyssey

Honda operates five automobile plants in the U.S. more than any other international automaker.

Key Points: 
  • Honda operates five automobile plants in the U.S. more than any other international automaker.
  • Honda vehicles in the top 10 are the Alabama-made Honda Passport SUV,Ridgeline pickup, Odyssey minivan and Pilot SUV.
  • Three Ohio-made Acura models the Acura flagship, fourth generation MDX SUV, RDX premium sport crossover and TLX premium sport sedan placed 14th, 15th and 16th respectively.
  • All four of the Honda models in the top 10 Passport,Ridgeline, Odyssey and Pilot also were designed and developed by Honda engineers in the U.S. and are produced exclusively in Lincoln, Alabama.

Press release Biocartis Group NV: Biocartis Announces New Agreement with AstraZeneca for the Development and Marketing of a Companion Diagnostic Test for Tagrisso®

Retrieved on: 
Wednesday, June 22, 2022
Industry, COVID-19, RSV, Technology, Person, European Society for Medical Oncology, ESMO, Euronext, Hummel, Company, Paraffin, U.S. Securities and Exchange Commission, Sepsis, Polymerase, Oncology, Forward-looking statement, Growth, Poster, MDX, Structured Product Labeling, Nature, RT, Twitter, Lung cancer, Patient, Polymerase chain reaction, PCR, Melanoma, Sale

Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as for COVID-19, flu, RSV and sepsis.

Key Points: 
  • Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as for COVID-19, flu, RSV and sepsis.
  • This press release is not for distribution, directly or indirectly, in any jurisdiction where to do so would be unlawful.
  • This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Vince Staples is Behind the Wheel of Next-Gen Acura Integra in New Launch Campaign

Retrieved on: 
Thursday, June 2, 2022
Decentraland, Hotel manager, NSX, Partnership, 1991 NBA Finals, NFT, TLX, NBA Finals, Integra, 2019 Acura Grand Prix of Long Beach, Multimedia, MDX, Music, Sale, Your Turn, Staples, Vince, Vince Staples, ILX, Type S, Culture, RDX, Toy, Acura, Magic

TORRANCE, Calif., June 2, 2022 /PRNewswire/ -- The launch campaign for the next-gen Acura Integra starring renowned artist and creator Vince Staples debuts tonight during the NBA Finals. The innovative and new campaign, Your Turn (acura.us/magic), puts Staples behind the wheel of the new Integra with three TV spots set to tracks from his latest album, Ramona Park Broke My Heart. The 2023 Acura Integra goes on sale today at Acura dealerships nationwide.

Key Points: 
  • TORRANCE, Calif., June 2, 2022 /PRNewswire/ -- The launch campaign for the next-gen Acura Integra starring renowned artist and creator Vince Staples debuts tonight during the NBA Finals.
  • The 2023 Acura Integra goes on sale today at Acura dealerships nationwide.
  • "Partnering with Acura for the debut of the new Integra gave me a chance to combine my love of cars, culture, storytelling and the experiences accessible travel brings us," says Vince Staples.
  • "Vince Staples' artistic vision and musical style align very well with Acura's bold, youthful and challenging spirit," said Meliza Humphrey, Senior Manager, Acura Marketing.

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Retrieved on: 
Wednesday, May 25, 2022
Severe acute respiratory syndrome coronavirus 2, City, Infection, Gene, Common, Multimedia, RNA-dependent RNA polymerase, Health, Influenza, COVID-19, WHO, Hospital, Middle East respiratory syndrome, PCR, MDX, School, RSV, Nursing, N, CEO, Pharmaceutical industry, Vaccine

SEOUL, South Korea, May 25, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, today unveiled a global initiative for preemptive and routine PCR testing to help individuals stay safe and healthy while living in the COVID-19 era. Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks.

Key Points: 
  • Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks.
  • Seegene's initiative dubbed 'In-life PCR,' entails 1) asymptomatic testing for early virus detection 2) syndromic respiratory testing as anti-virus restrictions are eased and 3) boosting PCR test accessibility through affordable pricing.
  • "The '$12 PCR testing' campaign is expected to help Seegene deliver its commitment to making molecular diagnostics accessible to anyone," said Dr. Chun.
  • "I'm certain that routine PCR testing will be the best solution to help end the COVID-19 pandemic.

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Retrieved on: 
Wednesday, May 25, 2022
Severe acute respiratory syndrome coronavirus 2, City, Infection, Gene, Common, RNA-dependent RNA polymerase, Health, Influenza, COVID-19, WHO, Hospital, Middle East respiratory syndrome, PCR, MDX, School, RSV, Nursing, N, CEO, Pharmaceutical industry, Vaccine

SEOUL, South Korea, May 25, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, today unveiled a global initiative for preemptive and routine PCR testing to help individuals stay safe and healthy while living in the COVID-19 era. Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks.

Key Points: 
  • Dr. Jong-Yoon Chun, CEO of Seegene, says the initiative is designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks.
  • Seegene's initiative dubbed 'In-life PCR,' entails 1) asymptomatic testing for early virus detection 2) syndromic respiratory testing as anti-virus restrictions are eased and 3) boosting PCR test accessibility through affordable pricing.
  • "The '$12 PCR testing' campaign is expected to help Seegene deliver its commitment to making molecular diagnostics accessible to anyone," said Dr. Chun.
  • "I'm certain that routine PCR testing will be the best solution to help end the COVID-19 pandemic.

Global $98.2 Bn In-Vitro Diagnostics/IVD Market 2022-2026 by Product and Service, Technology, Application & End User - ResearchAndMarkets.com

Retrieved on: 
Monday, May 23, 2022
Biotechnology, Hospitals, Health, Oncology, Immunoassay, Diabetes, Microbiology, Hospital, Hemostasis, Conditional sentence, POC, Cardiology, Degenerative disease, Patient, Infection, Investment, Government, IVD, Coagulation, USD, Industry, Awareness, MDX, Adoption, Lists of diseases, Instrument, CAGR, HIV/AIDS, Acquisition, Growth, Prevalence, Cancer, Urine test strip, Data management, Medical device, Pharmaceutical industry, Hematology, Oncology, Technology, Nephrology, CNN International Europe/Middle East/Africa, Clinical urine tests

Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years.

Key Points: 
  • Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years.
  • However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the forecast period.
  • Based on product and service, the IVD market is segmented into reagents & kits, instruments, services, and data management software.
  • Based on the end user, the IVD market is segmented into hospital laboratories, clinical laboratories, academic institutes, POC (point-of-care) testing centers, patients, and other end users.

Experienced Hawaii Executive Rudy R. Marilla Named President of MDX Hawai'i

Retrieved on: 
Thursday, May 12, 2022
Senior, Business, Physician, MBA, Humana, Deloitte, Company, China Executive Leadership Academy in Pudong, MDX, Blue Cross Blue Shield Association, Patient, SVKM's NMIMS, Health, Australian Energy Market Operator, MPH, Marketing, UnitedHealth Group, Community benefits agreement, Instagram, Hawaii Medical Service Association, YouTube, Master of Business Administration, Hospital, Technology, University, Public health, American City Business Journals, Business administration, LinkedIn, HMSA, Harvard Business School, Twitter, Kellogg School, Eli Lilly and Company, Public, Management, Medicine, Health insurance, Kaiser Permanente, Northwestern University

AUSTIN, Texas, May 12, 2022 /PRNewswire/ -- Rudy R. Marilla, MBA, MPH, has been named President of MDX Hawai'i, an agilon health company.

Key Points: 
  • AUSTIN, Texas, May 12, 2022 /PRNewswire/ -- Rudy R. Marilla, MBA, MPH, has been named President of MDX Hawai'i, an agilon health company.
  • "We are delighted to welcome Rudy Marilla to MDX Hawai'i," says Michael Demand, Senior Vice President of Markets Operations for agilon health.
  • Headquartered in Honolulu, MDX Hawai'i, an agilon health company, has over 34 years of experience serving the people of Hawaii.
  • MDX Hawai'i is committed to providing outstanding healthcare options and services and helping seniors in Hawaii lead healthy lives.